fluoromisonidazole has been researched along with Experimental Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higashino, K; Kuge, Y; Masaki, Y; Nishijima, KI; Numata, Y; Shimizu, Y; Tamaki, N; Yoshioka, T; Zhao, S | 1 |
| Chen, X; Jacobson, O; Kiesewetter, DO; Niu, G; Srivatsan, A; Tong, X; Wang, Y; Wang, Z; Yang, X; Zheng, H | 1 |
| Cheguillaume, A; De Bast, M; de Groot, T; Gillart, J; Grégoire, V; Haustermans, K; Labar, D; Mahy, P | 1 |
| Chang, J; Fichtinger, G; Finn, RD; Kazanzides, P; Ling, CC; Wen, B; Zanzonico, P | 1 |
| Allen, PD; Cornelissen, B; Dilworth, JR; Falzone, N; Gouverneur, V; Hill, SA; Hueting, R; Hussien, K; Kersemans, V; Muschel, RJ; Smart, SC; Tredwell, M | 1 |
| Ametamey, SM; Honer, M; Schubiger, PA; Wyss, MT | 1 |
| Rofstad, EK | 1 |
| Cherif, A; Gretzer, MB; Kim, EE; Li, C; Podoloff, DA; Wallace, S; Yang, DJ | 1 |
| Chin, LK; Hofstrand, PD; Rasey, JS; Tewson, TJ | 1 |
| Ando, K; Aoki, M; Furusawa, Y; Kuwabara, Y; Maeda, M; Masuda, K; Sasaki, S; Yamamoto, F | 1 |
| Griffiths, JR; Maxwell, RJ; Workman, P | 1 |
11 other study(ies) available for fluoromisonidazole and Experimental Neoplasms
| Article | Year |
|---|---|
FMISO accumulation in tumor is dependent on glutathione conjugation capacity in addition to hypoxic state.
Topics: Cell Line, Tumor; Glutathione; Humans; Metabolic Clearance Rate; Misonidazole; Neoplasms, Experimental; Oxygen; Positron-Emission Tomography; Protein Binding; Radiopharmaceuticals; Tissue Distribution; Tumor Hypoxia | 2017 |
Monitoring Tumor Hypoxia Using (18)F-FMISO PET and Pharmacokinetics Modeling after Photodynamic Therapy.
Topics: Animals; Cell Hypoxia; Cell Line, Tumor; Cell Tracking; Heterografts; Humans; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Positron-Emission Tomography | 2016 |
Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor models.
Topics: Animals; Fluorine Radioisotopes; Hypoxia; Male; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiopharmaceuticals; Tissue Distribution | 2008 |
A robotic system for 18F-FMISO PET-guided intratumoral pO2 measurements.
Topics: Algorithms; Animals; Cell Hypoxia; Cell Line, Tumor; Fiber Optic Technology; Imaging, Three-Dimensional; Immunohistochemistry; Misonidazole; Neoplasms, Experimental; Oxygen; Positron-Emission Tomography; Rats; Rats, Nude; Robotics | 2009 |
Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation.
Topics: Adenocarcinoma; Anesthesia; Animals; Coordination Complexes; Copper Radioisotopes; Female; Fluorine Radioisotopes; Gases; Hypoxia; Mice; Mice, Inbred CBA; Misonidazole; Muscles; Neoplasms, Experimental; Organometallic Compounds; Organotechnetium Compounds; Oxygen; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Thiosemicarbazones; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2011 |
NanoPET imaging of [(18)F]fluoromisonidazole uptake in experimental mouse tumours.
Topics: Animals; Cell Hypoxia; Equipment Design; Equipment Failure Analysis; Feasibility Studies; Female; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Nude; Misonidazole; Nanotechnology; Neoplasms, Experimental; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2006 |
Radiation response of the cells of a human malignant melanoma xenograft. Effect of hypoxic cell radiosensitizers.
Topics: Animals; Cell Survival; Dose-Response Relationship, Radiation; Humans; In Vitro Techniques; Injections, Intraperitoneal; Male; Melanoma; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Oxygen; Radiation Tolerance; Radiation-Sensitizing Agents; Time Factors; Transplantation, Heterologous | 1981 |
Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia.
Topics: Animals; Autoradiography; Cell Hypoxia; Contrast Media; Female; Fluorine Radioisotopes; Male; Mammary Neoplasms, Experimental; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Rabbits; Rats; Rats, Inbred F344; Tissue Distribution; Tomography, Emission-Computed | 1995 |
Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia.
Topics: Animals; Binding Sites; Blood-Brain Barrier; Cell Hypoxia; Chromatography, High Pressure Liquid; Contrast Media; Cricetinae; Cricetulus; Etanidazole; Female; Fibroblasts; Fibrosarcoma; Fluorine Radioisotopes; Glioma; Lung; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Oxygen; Radionuclide Imaging; Radiopharmaceuticals; Rats; Sarcoma, Experimental; Time Factors; Tissue Distribution; Tumor Cells, Cultured | 1999 |
Synthesis and evaluation of 4-bromo-1-(3-[18F]fluoropropyl)-2-nitroimidazole with a low energy LUMO orbital designed as brain hypoxia-targeting imaging agent.
Topics: Animals; Biotransformation; Chemical Phenomena; Chemistry, Physical; CHO Cells; Cricetinae; Electrons; Fluorine Radioisotopes; Hypoxia, Brain; Lipids; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Tissue Distribution | 2002 |
Demonstration of tumor-selective retention of fluorinated nitroimidazole probes by 19F magnetic resonance spectroscopy in vivo.
Topics: Animals; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1989 |